share_log

歌禮製藥-B：翌日披露報表

ASCLETIS-B: Next Day Disclosure Return

香港交易所 ·  Feb 14 05:06
Summary by Moomoo AI
歌禮製藥有限公司於2024年2月14日提交了翌日披露報表，披露了自2023年12月19日至2024年2月14日期間的股份購回活動。該公司在此期間共購回67,600,000股普通股，佔已發行股份的6.2182%。最後一次購回發生在2024年2月14日，當日購回500,000股，每股價格介於HKD 1.69至HKD 1.75之間，總付出金額為HKD 861,690。根據報表，購回的股份並未註銷。歌禮製藥確認，所有購回活動均獲董事會批准，並符合香港聯合交易所有限公司主板及GEM上市規則的相關規定。
歌禮製藥有限公司於2024年2月14日提交了翌日披露報表，披露了自2023年12月19日至2024年2月14日期間的股份購回活動。該公司在此期間共購回67,600,000股普通股，佔已發行股份的6.2182%。最後一次購回發生在2024年2月14日，當日購回500,000股，每股價格介於HKD 1.69至HKD 1.75之間，總付出金額為HKD 861,690。根據報表，購回的股份並未註銷。歌禮製藥確認，所有購回活動均獲董事會批准，並符合香港聯合交易所有限公司主板及GEM上市規則的相關規定。
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on February 14, 2024, disclosing its share repurchase activities for the period from December 19, 2023 to February 14, 2024. The company repurchased a total of 67,600,000 shares of common stock during this period, representing 6.2182% of the issued shares. The last repurchase took place on 14 February 2024. 500,000 shares were repurchased on that day at a price of between HKD 1.69 and HKD 1.75 for a total payout of HKD 861,690. According to the report, the repurchased shares were not written off. ACORN PHARMACEUTICALS CONFIRMS THAT ALL REPURCHASES HAVE BEEN APPROVED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE MAIN BOARD OF HKEX LIMITED AND THE GEM LISTING RULES.
Song Pharmaceutical Co., Ltd. filed a Next Day Disclosure Report on February 14, 2024, disclosing its share repurchase activities for the period from December 19, 2023 to February 14, 2024. The company repurchased a total of 67,600,000 shares of common stock during this period, representing 6.2182% of the issued shares. The last repurchase took place on 14 February 2024. 500,000 shares were repurchased on that day at a price of between HKD 1.69 and HKD 1.75 for a total payout of HKD 861,690. According to the report, the repurchased shares were not written off. ACORN PHARMACEUTICALS CONFIRMS THAT ALL REPURCHASES HAVE BEEN APPROVED BY THE BOARD OF DIRECTORS AND COMPLY WITH THE RELEVANT REQUIREMENTS OF THE MAIN BOARD OF HKEX LIMITED AND THE GEM LISTING RULES.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more